Pimarane cyclooxygenase 2 (COX-2) inhibitor and its structure-activity relationship

被引：29
|
作者：
Suh, YG
Kim, YH
Park, MH
Choi, YH
Lee, HK
Moon, JY
Min, KH
Shin, DY
Jung, JK
Park, OH
Jeon, RA
Park, HS
Kang, SA
机构：
[1] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea
[2] Chungnam Univ, Coll Pharm, Taejon 305764, South Korea
[3] Univ Ulsan, Coll Med, Seoul 138040, South Korea
[4] Sookmyung Womens Univ, Coll Pharm, Seoul 140742, South Korea
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2001年 / 11卷 / 04期
关键词：
D O I：
10.1016/S0960-894X(01)00004-X
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The structure-activity relationship and molecular modelings of a novel pimarane COX-2 inhibitor are reported. Particularly, a series of linker extended analogues designed on the basis of these studies exhibited significantly enhanced COX-2 inhibitory activities and selectivities. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：559 / 562
页数：4
相关论文
共 50 条
  • [21] Increased cyclooxygenase-2 (COX-2) expression in acute myocardial infarction: Therapeutic target of a selective COX-2 inhibitor
    Saito, T
    Rodger, IW
    Hu, F
    Tayara, L
    Giaid, A
    CIRCULATION, 2000, 102 (18) : 271 - 271
  • [22] Expression of cyclooxygenase 2 (COX-2) in human glioma and in Vitro inhibition by a specific COX-2 inhibitor, NS-398
    Joki, T
    Heese, O
    Nikas, DC
    Bello, L
    Zhang, JP
    Kraeft, SK
    Seyfried, NT
    Abe, T
    Chen, LB
    Carroll, RS
    Black, PM
    CANCER RESEARCH, 2000, 60 (17) : 4926 - 4931
  • [23] CoMFA and comsia 3D QSAR studies on pimarane cyclooxygenase-2 (COX-2) inhibitors.
    Suh, YG
    Park, HJ
    Kim, YH
    Lee, KO
    Paek, SM
    Moon, SH
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U35 - U35
  • [24] COX-2 inhibitor
    Gotzsche, P. C.
    Bjarnasoni, N. H.
    RHEUMATOLOGY, 2007, 46 (10) : 1623 - 1624
  • [25] Glycosylation of cyclooxygenase-2 (COX-2) influences effectiveness of COX-2 inhibitors
    Graham, Kamara Whitney
    Sevigny, Mary B.
    Gabriel, Bianca S.
    FASEB JOURNAL, 2009, 23
  • [26] Cyclooxygenase (COX)-1 Activity Precedes the COX-2 Induction in Aβ-Induced Neuroinflammation
    Leila Dargahi
    Shiva Nasiraei-Moghadam
    Azadeh Abdi
    Leila Khalaj
    Fatemeh Moradi
    Abolhassan Ahmadiani
    Journal of Molecular Neuroscience, 2011, 45 : 10 - 21
  • [27] Cyclooxygenase (COX)-1 Activity Precedes the COX-2 Induction in Aβ-Induced Neuroinflammation
    Dargahi, Leila
    Nasiraei-Moghadam, Shiva
    Abdi, Azadeh
    Khalaj, Leila
    Moradi, Fatemeh
    Ahmadiani, Abolhassan
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2011, 45 (01) : 10 - 21
  • [28] Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis
    Watson, DJ
    Harper, SE
    Zhao, PL
    Quan, H
    Bolognese, JA
    Simon, TJ
    ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (19) : 2998 - 3003
  • [29] Chemopreventive Efficacy of the Cyclooxygenase-2 (Cox-2) Inhibitor, Celecoxib, Is Predicted by Adenoma Expression of Cox-2 and 15-PGDH
    Wang, Jiping
    Cho, Nancy L.
    Zauber, Ann G.
    Hsu, Meier
    Dawson, Dawn
    Srivastava, Amitabh
    Mitchell-Richards, Kisha A.
    Markowitz, Sanford D.
    Bertagnolli, Monica M.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) : 728 - 736
  • [30] Modification of cyclooxygenase-2 (COX-2) inhibitor potency by lipid hydroperoxide (ROOH).
    Quellet, M
    Claveau, D
    Guay, J
    Riendeau, D
    Percival, MD
    FASEB JOURNAL, 2000, 14 (08): : A1522 - A1522
12345